Publications

Detailed Information

Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment

DC Field Value Language
dc.contributor.authorKim, Mi-Kyung-
dc.contributor.authorKim, Hee Seung-
dc.contributor.authorOh, Jung-Min-
dc.contributor.authorKim, Su-Hyeong-
dc.contributor.authorJuhnn, Yong-Sung-
dc.contributor.authorSong, Yong-Sang-
dc.contributor.authorLim, Jeong Mook-
dc.contributor.authorHan, Jae Yong-
dc.date.accessioned2012-06-04T05:20:56Z-
dc.date.available2012-06-04T05:20:56Z-
dc.date.issued2010-12-15-
dc.identifier.citationBIOCHEMICAL PHARMACOLOGY; Vol.80 12; 1930-1935ko_KR
dc.identifier.issn0006-2952-
dc.identifier.urihttps://hdl.handle.net/10371/76778-
dc.description.abstractHuman papillomavirus (HPV) infection is considered to be the necessary cause of cervical cancer. E6 and E7 oncoproteins of HPV have been known to play major roles in malignant transformation of cervical cells, inhibiting the tumor suppressors p53 and Rb. However, the role of E5 oncoprotein has been relatively less defined. HPV 16 E5 is a hydrophobic membrane-bound protein which associates with the Golgi apparatus, endoplasmic reticulum and perinuclear membrane. Accumulating evidences have suggested that E5 oncoprotein may also contribute to cervical carcinogenesis through modulating cellular signaling pathways in addition to augmenting the immortalization potential of E6 and E7. Multiple mechanisms, including activation of EGFR or inflammatory cell signaling pathway, have been implicated in malignant transformation by HPV 16 E5. Therefore, targeting E5 may be a rational approach for chemoprevention and treatment of cervical cancer, and understanding its oncogenic processes may help us to design novel therapeutic strategies. In this review, we discussed the roles of HPV 16 E5 in cervical carcinogenesis, altering several cellular signaling pathways involved in cell proliferation, angiogenesis and apoptosis. (C) 2010 Elsevier Inc. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherPERGAMON-ELSEVIER SCIENCE LTDko_KR
dc.subjectHuman papillomavirusko_KR
dc.subjectCOX-2ko_KR
dc.subjectCervical cancerko_KR
dc.subjectEGFRko_KR
dc.subjectE5ko_KR
dc.titleHuman papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatmentko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor임정묵-
dc.contributor.AlternativeAuthor전용성-
dc.contributor.AlternativeAuthor송용상-
dc.contributor.AlternativeAuthor김수형-
dc.contributor.AlternativeAuthor김미경-
dc.contributor.AlternativeAuthor한재용-
dc.contributor.AlternativeAuthor오정민-
dc.contributor.AlternativeAuthor김희승-
dc.identifier.doi10.1016/j.bcp.2010.07.013-
dc.citation.journaltitleBIOCHEMICAL PHARMACOLOGY-
dc.description.citedreferenceSmith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527-
dc.description.citedreferenceMaufort JP, 2007, CANCER RES, V67, P6106, DOI 10.1158/0008-5472.CAN-07-0921-
dc.description.citedreferencePaavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5-
dc.description.citedreferenceVilla LL, 2007, NEW ENGL J MED, V356, P1915-
dc.description.citedreferenceFerrandina G, 2002, J CLIN ONCOL, V20, P973-
dc.description.citedreferencezur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798-
dc.description.citedreferenceKabsch K, 2002, J VIROL, V76, P12162, DOI 10.1128/JVI.76.23.12162-12172.2002-
dc.description.citedreferenceClifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688-
dc.description.citedreferenceKim MH, 2003, GYNECOL ONCOL, V90, P83, DOI 10.1016/S0090-8258(03)00224-5-
dc.description.citedreferenceChen YF, 2004, J VIROL, V78, P1333, DOI 10.1128/JVI.78.3.1333-1343.2004-
dc.description.citedreferenceToussaint-Smith E, 2004, ONCOGENE, V23, P2988, DOI 10.1038/sj.onc.1207442-
dc.description.citedreferenceFilippova M, 2004, J BIOL CHEM, V279, P25729, DOI 10.1074/jbc.M401172200-
dc.description.citedreferenceMoore DH, 2004, J CLIN ONCOL, V22, P3113, DOI 10.1200/JCO.2004.04.170-
dc.description.citedreferenceOhta Y, 1999, ANN THORAC SURG, V68, P1034-
dc.description.citedreferenceKondo M, 1999, CLIN CANCER RES, V5, P4005-
dc.description.citedreferenceHanahan D, 2000, CELL, V100, P57-
dc.description.citedreferenceCrusius K, 2000, VIRUS GENES, V20, P65-
dc.description.citedreferenceDas H, 2000, BRIT J CANCER, V82, P1682-
dc.description.citedreferenceTomakidi P, 2000, EUR J CELL BIOL, V79, P407-
dc.description.citedreferenceTomakidi P, 2000, CELL TISSUE RES, V301, P323-
dc.description.citedreferenceLiu DW, 2000, J VIROL, V74, P9083-
dc.description.citedreferenceCheng WF, 2000, OBSTET GYNECOL, V96, P721-
dc.description.citedreferenceSTRAIGHT SW, 1995, J VIROL, V69, P3185-
dc.description.citedreferenceVALLE GF, 1995, J GEN VIROL, V76, P1239-
dc.description.citedreferenceOELZE I, 1995, J VIROL, V69, P4489-
dc.description.citedreferenceHWANG ES, 1995, VIROLOGY, V211, P227-
dc.description.citedreferenceGU ZM, 1995, J VIROL, V69, P8051-
dc.description.citedreferenceChen SL, 1996, ARCH VIROL, V141, P791-
dc.description.citedreferenceHanahan D, 1996, CELL, V86, P353-
dc.description.citedreferenceTsao YP, 1996, J VIROL, V70, P7535-
dc.description.citedreferenceChen SL, 1996, J VIROL, V70, P8558-
dc.description.citedreferenceSCHWARZ E, 1985, NATURE, V314, P111-
dc.description.citedreferenceDYSON N, 1989, SCIENCE, V243, P934-
dc.description.citedreferenceWERNESS BA, 1990, SCIENCE, V248, P76-
dc.description.citedreferenceSCHEFFNER M, 1990, CELL, V63, P1129-
dc.description.citedreferenceFOLKMAN J, 1991, PRINCESS TAKAMATSU S, V22, P339-
dc.description.citedreferenceLEECHANACHAI P, 1992, ONCOGENE, V7, P19-
dc.description.citedreferencePIM D, 1992, ONCOGENE, V7, P27-
dc.description.citedreferenceSTRAIGHT SW, 1993, J VIROL, V67, P4521-
dc.description.citedreferenceCONRAD M, 1993, J VIROL, V67, P6170-
dc.description.citedreferenceZURHAUSEN H, 1994, ANNU REV MICROBIOL, V48, P427-
dc.description.citedreferenceBOUVARD V, 1994, VIROLOGY, V203, P73-
dc.description.citedreferenceEBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183-
dc.description.citedreferenceRistimaki A, 1997, CANCER RES, V57, P1276-
dc.description.citedreferencePaley PJ, 1997, CANCER, V80, P98-
dc.description.citedreferenceCrusius K, 1997, ONCOGENE, V15, P1437-
dc.description.citedreferenceCrusius K, 1998, EXP CELL RES, V241, P76-
dc.description.citedreferenceGross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058-
dc.description.citedreferenceVenuti A, 1998, VIROLOGY, V248, P1-
dc.description.citedreferenceIshigami SI, 1998, BRIT J CANCER, V78, P1379-
dc.description.citedreferenceThomas M, 1998, ONCOGENE, V17, P2943-
dc.description.citedreferenceKulkarni S, 2001, CLIN CANCER RES, V7, P429-
dc.description.citedreferenceChang JL, 2001, J BIOMED SCI, V8, P206, DOI 10.1159/000054034-
dc.description.citedreferenceGaffney DK, 2001, INT J RADIAT ONCOL, V49, P1213-
dc.description.citedreferenceSales KJ, 2001, J CLIN ENDOCR METAB, V86, P2243-
dc.description.citedreferenceDiMaio D, 2001, ONCOGENE, V20, P7866-
dc.description.citedreferenceZhang BY, 2002, J VIROL, V76, P220, DOI 10.1128/JVI.76.1.220-231.2002-
dc.description.citedreferenceMutoh M, 2002, CANCER RES, V62, P28-
dc.description.citedreferenceKabsch K, 2002, ONCOGENE, V21, P947-
dc.description.citedreferenceDannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112-
dc.description.citedreferenceParkin DM, 2005, CA-CANCER J CLIN, V55, P74-
dc.description.citedreferenceKim JY, 2005, GYNECOL ONCOL, V97, P337, DOI 10.1016/j.ygyno.2004.09.012-
dc.description.citedreferenceWilliams SMG, 2005, CANCER RES, V65, P6534-
dc.description.citedreferenceMa XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348-
dc.description.citedreferenceChell SD, 2006, CANCER RES, V66, P3106-
dc.description.citedreferenceHefler LA, 2006, EUR J OBSTET GYN R B, V125, P251, DOI 10.1016/j.ejogrb.2005.08.019-
dc.description.citedreferenceKim K, 2009, ANN NY ACAD SCI, V1171, P111, DOI 10.1111/j.1749-6632.2009.04724.x-
dc.description.citedreferenceOh JM, 2009, CARCINOGENESIS, V30, P141, DOI 10.1093/carcin/bgn236-
dc.description.citedreferenceGreenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014-
dc.description.citedreferenceKim SH, 2009, CARCINOGENESIS, V30, P753, DOI 10.1093/carcin/bgp066-
dc.description.citedreferenceMonk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909-
dc.description.citedreferenceOh JM, 2010, CARCINOGENESIS, V31, P402, DOI 10.1093/carcin/bgp318-
dc.description.citedreferenceMaufort JP, 2010, CANCER RES, V70, P2924, DOI 10.1158/0008-5472.CAN-09-3436-
dc.description.citedreferencePedroza-Saavedra A, 2010, VIROLOGY, V400, P44, DOI 10.1016/j.virol.2010.01.009-
dc.description.citedreferenceWang W, 2010, CANCER LETT, V291, P67, DOI 10.1016/j.canlet.2009.09.022-
dc.description.citedreferenceArechaga-Ocampo E, 2008, GYNECOL ONCOL, V108, P10, DOI 10.1016/j.ygyno.2007.08.070-
dc.description.citedreferenceSima N, 2008, APOPTOSIS, V13, P273, DOI 10.1007/s10495-007-0163-8-
dc.description.citedreferenceSpannuth WA, 2008, NAT CLIN PRACT ONCOL, V5, P194, DOI 10.1038/ncponc1051-
dc.description.citedreferenceKerbel RS, 2008, NEW ENGL J MED, V358, P2039-
dc.description.citedreferenceJonson AL, 2008, GYNECOL ONCOL, V111, P356, DOI 10.1016/j.ygyno.2008.06.033-
dc.description.citedreferenceTang XD, 2007, CLIN CANCER RES, V13, P2568, DOI 10.1158/1078-0432.CCR-06-2704-
dc.description.citedreferenceSubbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273-
dc.description.citedreferenceChen SL, 2007, ONCOGENE, V26, P42, DOI 10.1038/sj.onc.1209768-
dc.description.citedreferenceWANG XG, 2007, PLOS ONE, V2, pNI251-
dc.description.citedreferenceFarley JH, 2006, GYNECOL ONCOL, V103, P425, DOI 10.1016/j.ygyno.2006.03.036-
dc.description.citedreferenceKang SB, 2006, CANCER LETT, V237, P305, DOI 10.1016/j.canlet.2005.06.027-
dc.description.citedreferenceKim SH, 2006, CELL MOL LIFE SCI, V63, P930, DOI 10.1007/s00018-005-5561-x-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share